Peritonitis Clinical Trial
— SMASHOfficial title:
Standardized Perioperative Management of Patients Operated With Acute Abdominal Surgery in a High-risk Emergency Setting
Verified date | October 2022 |
Source | Sahlgrenska University Hospital, Sweden |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The objective of the study is to handle patients with the need for an acute laparotomy according to a standardised perioperative protocol and to document the measurement as they are performed (i.e. adherence to the protocol) and to measure the outcome with regard to both short- (30 days) and long-term (3 and 12 months) mortality. Several secondary endpoints will be measured, such as: hospital stay, length of stay at an Intensive Care Unit (ICU), readmission to ICU and surgical complications according to the Clavien-Dindo score. These results will then be compared to published rates of mortality from the literature and to similar outcomes for a cohort of all patients operated at NÄL on the same indication the years prior to the project/study.
Status | Active, not recruiting |
Enrollment | 1435 |
Est. completion date | September 6, 2023 |
Est. primary completion date | June 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All patients with the need of an acute laparotomy at NÄL Exclusion Criteria: - Laparotomy planned in advance and without suspicion of an acute intraabdominal pathology. - Abdominal wall hernias (with no suspicion of ileus or bowel ischemia) - Appendectomy (Laparoskopically or open) - Cholecystectomi (Laparoskopically or open) - Acute thoracotomy - Akute aortic surgery - Planned second look-surgery (including change of open abdominal drapings/VAC) |
Country | Name | City | State |
---|---|---|---|
Sweden | Department of Surgery, NU-Hospital/NÄL | Trollhättan | Västra Götalandsregionen |
Lead Sponsor | Collaborator |
---|---|
Sahlgrenska University Hospital, Sweden | NU-Hospital Organization, Sweden |
Sweden,
Huddart S, Peden CJ, Swart M, McCormick B, Dickinson M, Mohammed MA, Quiney N; ELPQuiC Collaborator Group; ELPQuiC Collaborator Group. Use of a pathway quality improvement care bundle to reduce mortality after emergency laparotomy. Br J Surg. 2015 Jan;102 — View Citation
Tengberg LT, Bay-Nielsen M, Bisgaard T, Cihoric M, Lauritsen ML, Foss NB; AHA study group. Multidisciplinary perioperative protocol in patients undergoing acute high-risk abdominal surgery. Br J Surg. 2017 Mar;104(4):463-471. doi: 10.1002/bjs.10427. Epub — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Short term mortality | 30 days overall mortality following acute laparotomy | 30 days | |
Secondary | Long term mortality | 3-months overall mortality following acute laparotomy | 3 months | |
Secondary | Long term mortality | 12 months overall mortality following acute laparotomy | 12 months | |
Secondary | Hospital stay | Length of hospital stay for survivors following acute laparotomy | 12 months | |
Secondary | Intesive care need | The need for ICU-care following acute laparotomy | 12 months | |
Secondary | Intesive care need | The need for readmission to the ICU following acute laparotomy | 12 months | |
Secondary | Surgical complications | Surgical complications (according to the Clavien-Dindo score) following acute laparotomy | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04070196 -
Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT00657566 -
SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
|
Phase 3 | |
Recruiting |
NCT00131196 -
Functional Genomic Influences on Disease Progression and Outcome in Sepsis
|
N/A | |
Completed |
NCT00195351 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
|
Phase 4 | |
Completed |
NCT04182217 -
Descriptive and Correlational Study of Peritonitis in Haiti.
|
||
Recruiting |
NCT03310606 -
Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis
|
N/A | |
Completed |
NCT01222663 -
Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock
|
Phase 3 | |
Completed |
NCT00230971 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
|
Phase 4 | |
Recruiting |
NCT03790176 -
ZAVI APD ELF Protocol v2.2
|
Phase 1 | |
Completed |
NCT03668197 -
Children Peritonitis Ecology at CHU de Rennes - (IIAPEDIA)
|
||
Recruiting |
NCT01837342 -
Multicenter Study Comparing Morbidity and Quality of Life Associated in the Treatment by Surgical Resection and the Conservative Treatment, After Favorable Evolution of Purulent Peritonitis That Originates From Diverticulitis Treated by Mini-invasive Surgery
|
N/A | |
Completed |
NCT00497744 -
A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis
|
N/A | |
Recruiting |
NCT03334006 -
Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis (PEPPER Trial).
|
Phase 2 | |
Terminated |
NCT03403751 -
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
|
Phase 3 | |
Withdrawn |
NCT00463762 -
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
|
Phase 4 | |
Active, not recruiting |
NCT02755610 -
Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis
|
N/A | |
Not yet recruiting |
NCT05308849 -
Peritoneal Diffusion and Efficacy of Antibiotic Therapy in Pediatric Peritonitis
|
N/A | |
Completed |
NCT02726932 -
Intra-abdominal View and Inflammatory Markers in Secondary Peritonitis - Correlation to Recovery
|
||
Recruiting |
NCT05050253 -
Lavage With Super-Oxidized Solution for Secondary Peritonitis
|
N/A | |
Completed |
NCT02926846 -
IV Antibiotics With Lavage for Severe PD Peritonitis
|
Phase 4 |